• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Champions Oncology, Inc. - Common Stock (NQ:CSBR)

    6.050 -0.380 (-5.91%)
    Streaming Delayed Price Updated: 9:42 AM EDT, Jun 30, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Champions Oncology, Inc. - Common Stock

    < Previous 1 2 3 4 5 Next >
    News headline image
    Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026
    Via ACCESS Newswire
    News headline image
    Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
    Via ACCESS Newswire
    News headline image
    Champions Oncology (CSBR) Earnings Transcript ↗
    Champions Oncology (CSBR) Earnings Transcript 
    Via The Motley Fool
    Champions Oncology Inc. (NASDAQ:CSBR) Shares Surge on Record Study Revenue Despite Q3 Earnings Miss ↗
    Via Chartmill
    News headline image
    Champions Oncology Reports Revenue of $16.6 Million
    Via ACCESS Newswire
    News headline image
    Insights Ahead: Champions Oncology's Quarterly Earnings ↗
     
    Via Benzinga
    News headline image
    Champions Oncology Reports Record Annual Revenue of $57 Million
    Via ACCESS Newswire
    News headline image
    Earnings Scheduled For July 23, 2025 ↗
     
    Via Benzinga
    News headline image
    Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026
    Via ACCESS Newswire
    News headline image
    Fund Discloses $25 Million Braze Stock Investment Amid 60% Share Plunge ↗
    This SaaS provider enables brands to personalize customer engagement across digital channels using data-driven orchestration tools. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Battery Management Dumps $9 Million Zeta Stake as Shares Slide 38% Year Over Year ↗
    This marketing technology provider delivers data-driven automation and consumer insights to enterprise clients across multiple channels. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Battery Takes $124 Million Bet on Kodiak AI. Here's What Investors Should Know ↗
    Kodiak AI, Inc. delivers AI-powered navigation software for trucking, defense, and industrial fleets using proprietary sensor technology. 
    Via The Motley Fool
    Topics Artificial Intelligence Regulatory Compliance
    News headline image
    Sprinklr Stock Down 40% in a Year as One Fund Sells Nearly $3 Million Worth of Shares ↗
    Sprinklr delivers a unified platform for enterprise customer experience management, serving global brands with integrated digital solutions. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Champions Oncology (CSBR) Earnings Call Transcript ↗
    Champions Oncology (CSBR) Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings
    News headline image
    Champions Oncology (CSBR) Earnings Transcript ↗
    Champions Oncology (CSBR) Earnings Transcript 
    Via The Motley Fool
    News headline image
    Champions Oncology Inc (NASDAQ:CSBR) Beats Revenue Estimates and Returns to Profitability in Q2 ↗
    Champions Oncology beats Q2 revenue estimates, returns to profit with record service revenue and expanding margins. 
    Via Chartmill
    News headline image
    Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million
    Via ACCESS Newswire
    News headline image
    CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million
    Via ACCESS Newswire
    News headline image
    Champions Oncology Inc (NASDAQ:CSBR) Reports Q1 Fiscal 2026 Earnings with Record Revenue but Wider-Than-Expected Loss ↗
    Champions Oncology posts record Q1 FY26 revenue of $14.0M but reports a wider-than-expected loss due to increased strategic investments in its data platform. 
    Via Chartmill
    News headline image
    Champions Oncology Reports Record Quarterly Revenue of $14.0 Million
    Via ACCESS Newswire
    News headline image
    Earnings Scheduled For September 15, 2025 ↗
     
    Via Benzinga
    News headline image
    Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025
    Via ACCESS Newswire
    News headline image
    4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week ↗
    Several biotech stocks have seen their strength fade over the past week, with their Momentum scores in Benzinga's Edge Stock Rankings witnessing a significant decline. 
    Via Benzinga
    News headline image
    Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025
    Via ACCESS Newswire
    News headline image
    Champions Oncology Announces Appointment of New CEO
    Via ACCESS Newswire
    News headline image
    Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models
    Via ACCESS Newswire
    News headline image
    Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House
    Via ACCESS Newswire
    News headline image
    Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine
    Via ACCESS Newswire
    News headline image
    Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million
    Via ACCESS Newswire
    News headline image
    Earnings Scheduled For March 11, 2025 ↗
     
    Via Benzinga
    < Previous 1 2 3 4 5 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.